45 related articles for article (PubMed ID: 23392229)
1. Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.
Yip PY; Yu B; Cooper WA; Selinger CI; Ng CC; Kennedy CW; Kohonen-Corish MR; McCaughan BC; Trent RJ; Boyer MJ; Kench JG; Horvath LG; O'Toole SA
J Thorac Oncol; 2013 Apr; 8(4):408-14. PubMed ID: 23392229
[TBL] [Abstract][Full Text] [Related]
2. Real-world applications of the new grading system in lung adenocarcinoma: A study of 907 patients focusing on revealing the relationship between pathologic grade and genetic status.
Liu XL; Li D; Wan WB; Song YL; Li GQ; Lin DL
Ann Diagn Pathol; 2024 Aug; 71():152328. PubMed ID: 38754357
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and molecular characterization of resected lung adenocarcinoma: Correlations with histopathological grading systems in Chinese patients.
Xia W; Zhang S; Ye Y; Xiao H; Zhang Y; Ning G; Zhang Y; Wang W; Fei GH
Pathol Res Pract; 2024 Jul; 259():155359. PubMed ID: 38810376
[TBL] [Abstract][Full Text] [Related]
4. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Rekhtman N; Tafe LJ; Chaft JE; Wang L; Arcila ME; Colanta A; Moreira AL; Zakowski MF; Travis WD; Sima CS; Kris MG; Ladanyi M
Mod Pathol; 2013 Apr; 26(4):511-22. PubMed ID: 23196793
[TBL] [Abstract][Full Text] [Related]
5. Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers.
Ahn JW; Kim HS; Yoon JK; Jang H; Han SM; Eun S; Shim HS; Kim HJ; Kim DJ; Lee JG; Lee CY; Bae MK; Chung KY; Jung JY; Kim EY; Kim SK; Chang J; Kim HR; Kim JH; Lee MG; Cho BC; Lee JH; Bang D
Genome Med; 2014; 6(2):18. PubMed ID: 24576404
[TBL] [Abstract][Full Text] [Related]
6. A genomics-based classification of human lung tumors.
;
Sci Transl Med; 2013 Oct; 5(209):209ra153. PubMed ID: 24174329
[TBL] [Abstract][Full Text] [Related]
7. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
[TBL] [Abstract][Full Text] [Related]
8. CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer.
Akbari Kordkheyli V; Rashidi M; Shokri Y; Fallahpour S; Variji A; Nabipour Ghara E; Hosseini SM
Adv Pharm Bull; 2022 Mar; 12(2):262-273. PubMed ID: 35620343
[TBL] [Abstract][Full Text] [Related]
9. TNM stages inversely correlate with the age at diagnosis in
Tang W; Lei Y; Su J; Zhang C; Fu R; Kang J; Yan H; Yang X; Tu H; Wu Y; Zhong W
Transl Lung Cancer Res; 2019 Apr; 8(2):144-154. PubMed ID: 31106125
[TBL] [Abstract][Full Text] [Related]
10. Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis.
Kalainayakan SP; FitzGerald KE; Konduri PC; Vidal C; Zhang L
Cell Biosci; 2018; 8():56. PubMed ID: 30410721
[TBL] [Abstract][Full Text] [Related]
11. An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.
Ahmadzada T; Kao S; Reid G; Boyer M; Mahar A; Cooper WA
J Clin Med; 2018 Jun; 7(6):. PubMed ID: 29914100
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the management of non-small cell lung cancer.
Shojaee S; Nana-Sinkam P
F1000Res; 2017; 6():2110. PubMed ID: 29259780
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer.
Wu JY; Shih JY
Onco Targets Ther; 2016; 9():6137-6145. PubMed ID: 27785061
[TBL] [Abstract][Full Text] [Related]
14. Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
Selinger CI; Li BT; Pavlakis N; Links M; Gill AJ; Lee A; Clarke S; Tran TN; Lum T; Yip PY; Horvath L; Yu B; Kohonen-Corish MR; O'Toole SA; Cooper WA
Histopathology; 2017 Feb; 70(3):402-411. PubMed ID: 27599111
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey.
Sag SO; Gorukmez O; Ture M; Gorukmez O; Deligonul A; Sahinturk S; Topak A; Gulten T; Kurt E; Yakut T
Springerplus; 2016; 5():482. PubMed ID: 27217997
[TBL] [Abstract][Full Text] [Related]
16. Somatic DNA mutation analysis in targeted therapy of solid tumours.
Yu B; O'Toole SA; Trent RJ
Transl Pediatr; 2015 Apr; 4(2):125-38. PubMed ID: 26835368
[TBL] [Abstract][Full Text] [Related]
17. L858R-positive lung adenocarcinoma with KRAS G12V, EGFR T790M and EGFR L858R mutations: A case report.
Xiang X; Yu J; Lai Y; He W; Li S; Wang L; Ke Z
Oncol Lett; 2015 Sep; 10(3):1293-1296. PubMed ID: 26622666
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutations in non-small cell lung cancer.
Luk PP; Yu B; Ng CC; Mercorella B; Selinger C; Lum T; Kao S; O'Toole SA; Cooper WA
Transl Lung Cancer Res; 2015 Apr; 4(2):142-8. PubMed ID: 25870796
[TBL] [Abstract][Full Text] [Related]
19. The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer.
Wang S; Yu B; Ng CC; Mercorella B; Selinger CI; O'Toole SA; Cooper WA
Transl Lung Cancer Res; 2015 Apr; 4(2):119-25. PubMed ID: 25870794
[TBL] [Abstract][Full Text] [Related]
20. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
Wen YS; Cai L; Zhang XW; Zhu JF; Zhang ZC; Shao JY; Zhang LJ
Medicine (Baltimore); 2014 Dec; 93(29):e296. PubMed ID: 25546673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
